LDGs versus NDGs in patients with oral squamous cell carcinoma (OSCC).

Marzena Garley, Ewa Jabłońska, Dorota Dziemiańczyk-Pakieła, Wojciech Miltyk, Wioletta Ratajczak-Wrona, Jan Borys, Marcin Moniuszko, Kamil Grubczak

Cytokine 2021 Jan

filter terms:

The significant role played by neutrophils in cancer biology is indisputable; yet, their subpopulations may exhibit a contrasting role. The phenomenon of polarization of neutrophils and signaling modulators in the course of a neoplastic process has gained increased attention in recent times. The present study's objective was to quantitatively assess low-density neutrophils (LDNs) and normal-density neutrophils (NDNs) populations including IL-17 expression in confrontation with Th17 lymphocytes in patients with oral squamous cell carcinoma (OSCC). The neutrophil to lymphocyte ratio (NLR) biomarker value was determined. Besides, the influence of rhIL-17 on the proliferation level of the squamous cell carcinoma (SCC) malignant line cells was tested. Leukocytes were isolated in the density gradient and the CD16+ population was magnetically sorted. The percentages of neutrophil subpopulations, lymphocyte Th17, and IL-17 expression in the studied cells were determined on a flow cytometer. Squamous cell carcinoma proliferation was assessed with the MTT test. The existence of two populations of human neutrophils was determined: LDNs and NDNs. A higher percentage of LDNs and Th17 was observed with the concomitant lower percentage of NDNs in patients with OSCC as compared with the control group. NLR was elevated in patients with cancer. The highest IL-17 expression was obtained in the LDNs population in these patients. However, no influence of IL-17 on SCC proliferation could be determined. The present study demonstrated a strong relationship between IL-17 concentration and the count of LDNs or Th17 in the course of OSCC, which may serve as a reference point for new therapies. Moreover, the obtained LDNs/NDNs and NLR values in patients with cancer prove their usefulness in diagnostic and prognostic in patients with OSCC. Copyright © 2020 Elsevier Ltd. All rights reserved.

Citation

Marzena Garley, Ewa Jabłońska, Dorota Dziemiańczyk-Pakieła, Wojciech Miltyk, Wioletta Ratajczak-Wrona, Jan Borys, Marcin Moniuszko, Kamil Grubczak. LDGs versus NDGs in patients with oral squamous cell carcinoma (OSCC). Cytokine. 2021 Jan;137:155311